VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HSIC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HSICHenry Schein, Inc.
$86.05$9.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HSIC logo

Henry Schein, Inc.

HSIC
NASDAQ · Drug Distributors & Pharmacies
$86.05
At close - Nov 6, 4:00 PM EST - USD
Market Cap$9.8B
P/E23.0x
52W High$92.18
Volume1.37M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Steady Distribution Growth Meets Rising Leverage Concerns

Henry Schein's revenue has grown from roughly $3.1B in Q2 2024 to $3.5B in Q3 2026, with year-over-year growth between 4.0% and 7.7%, and gross margin holding within a narrow 28.7% to 31.8% band.

GrowthStable
ProfitabilityStable
ValuationAttractive
TechnicalsMixed
Explore valuation models
MARKET ACTION

HSIC price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

9/12 Beats

EPS beat 9 of last 12 quarters

02

Valuation risk

-34% Peers

P/E is 34% below peer median

03

Market leadership

RS 69 · Avg

Average momentum (RS Rating: 69)

04

Mixed Trend

Mixed

Price < 50DMA but > 200DMA

Next CatalystEstimated earnings · Feb 3
01

Build the investment case

Start with the evidence for owning the stock and the risks that can break the thesis.

EXECUTIVE THESIS

The Investment Case

Full Analysis
Fundamental Trajectory

Revenue grew steadily to $3.5B with gross margin of 29.8% to 31.8% in recent quarters, but operating margin of 5.4% to 6.5% suggests SG&A growth has absorbed much of the gross profit gains.

Analyst Consensus+12.9% target
Buy(34 analysts)
17 Buy14 Hold3 Sell

The Bull Case

Upside Catalysts

Strong earnings performance

Henry Schein reported adjusted earnings per share of $1.32 and net sales of $3.37b, exceeding expectations and attracting investor interest.

Leadership and transformation

The company's growth is driven by a new CEO, private-label expansion, and operational efficiency under KKR's restructuring.

AI-driven opportunities

Henry Schein is leveraging AI-driven software to enhance its business model and create new growth avenues.

The Bear Case

Key Downside Risks

Market performance

Price History →

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
HSIC+12.02%
S&P 500 (^GSPC)+7.63%
1-Year Return
HSIC+22.82%
S&P 500 (^GSPC)+9.69%
3-Year Return
HSIC+37.39%
S&P 500 (^GSPC)+70.13%
5-Year Return
HSIC+9.42%
S&P 500 (^GSPC)+58.06%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/EMedian
23.0x
Forward P/EExpansion
15.7x
EV/EBITDA60th %ile
11.9x
FCF YieldCash Flow
5.4%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
23.0x
23.1x
40th· Fair
EV/EBITDA
11.9x
11.8x
60th· Fair
Price/FCF
18.5x
17.4x
60th· Fair
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$47.33-45.0%
Base (Fair)$104.38+21.3%
Bull$196.67+128.6%
$47.33 Bear$104.38 Base$196.67 Bull
Current Market Price: $86.05
Trades at a 17.6% discount to Base DCF ($104.38)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$13.18B+4.0% YoY
Net income FY25
$398M+2.1% YoY
Free cash flow FY25
$573M-13.3% YoY
Operating margin FY25
5.7%-0.0 pts YoY
ROIC (FY25)7.1%
Avg ROIC 5Y9.2%
ROE (TTM)8.8%
Piotroski Score4 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate9/12 (75%)
Revenue Beat Rate3/12 (25%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Nov 3, 2026
$1.37+0.7%
vs $1.36
$3.5B-0.1%
vs $3.5B
Q3 2026
Aug 4, 2026
$1.27+2.4%
vs $1.24
$3.5B+2.5%
vs $3.4B
Q2 2026
May 5, 2026
$1.32+10.0%
vs $1.20
$3.4B+0.8%
vs $3.3B
Q1 2026
Feb 24, 2026
$1.34+3.1%
vs $1.30
$3.4B+2.7%
vs $3.3B
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Zacks Investment Research·Oct 27, 2026
Analysts Estimate Henry Schein (HSIC) to Report a Decline in Earnings: What to Look Out for

Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research·Oct 27, 2026
Henry Schein to Report Q3 Earnings: Here's What You Should Know

HSIC gears up for Q3 earnings with revenue growth expected across its three segments, fueled by dental products, specialty demand and cloud-based technology.

Business Wire·Oct 20, 2026
Henry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ET

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its third quarter 2026 financial results before the stock market opens on Tuesday, November 3, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Fred Lowery, Chief Executive Officer, R.

Zacks Investment Research·Oct 19, 2026
Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Filtered for Henry Schein, Inc.More Headlines
04

Compare before deciding

Benchmark HSIC against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Henry Schein, Inc. (HSIC)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
HSIC logoHSICHenry Schein, Inc.Current
$86.05$9.8B23.004.03%3.07%8.83%—
DXPE logoDXPEDXP Enterprises, Inc.
$140.68$2.18B23.3811.89%4.45%18.55%0%
ACH logoACHAccendra Health, Inc.
$0.20$15.62M-0.01-74.19%-6.72%——
MCK logoMCKMcKesson Corporation
$1060.84$123.8B26.3412.36%1.12%—0.29%
CAH logoCAHCardinal Health, Inc.
$271.72$63.64B34.8214.23%0.71%—0.76%
XRAY logoXRAYDENTSPLY SIRONA Inc.
$9.46$1.9B-15.57-2.98%-3.38%-9.02%6.79%

Compare HSIC vs Peers

Henry Schein, Inc. (HSIC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs DXPE

Most directly comparable listed peer for HSIC.

Scale Benchmark

vs SYK

Larger-name benchmark to compare HSIC against a more recognizable public peer.

Peer Set

Compare Top 5

vs DXPE, ACH, MCK, CAH

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

HSIC SEC Filings & Documents

Henry Schein, Inc. (HSIC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Nov 3, 2026·SEC

Material company update

Oct 8, 2026·SEC

Material company update

Aug 4, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 25, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

Nov 3, 2026·SEC

FY 2026

Aug 4, 2026·SEC

FY 2026

May 5, 2026·SEC

Get notified when HSIC posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

HSIC Frequently Asked Questions

Henry Schein, Inc. (HSIC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Henry Schein, Inc.'s revenue?

Henry Schein, Inc. (HSIC) reported $13.73B in revenue over the trailing twelve months. Revenue was $13.18B in fiscal year 2025. That is 1488% more than the $830.0M of fiscal year 1996.

How fast is Henry Schein, Inc. growing?

Henry Schein, Inc. (HSIC) grew revenue by 6.2% over the trailing twelve months, compared with the twelve months before.

Is HSIC profitable?

Yes. Henry Schein, Inc. (HSIC) earned $421.0M in net income over the trailing twelve months (a 3.1% net margin).

Dividend & Returns
What is HSIC's return on equity?

Henry Schein, Inc. (HSIC) had a return on equity (ROE) of 8.8% over the trailing twelve months. That is below the market's typical 10-15%.

What is Henry Schein, Inc.'s free cash flow?

Henry Schein, Inc. (HSIC) generated $529.0M in free cash flow over the trailing twelve months.

What if you invested $1,000 in HSIC back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →